Chongqing Zhongbang Technology Co., Ltd.

Chongqing Zhongbang Technology Co., Ltd. is a national key high-tech company invested and established in Wanzhou, Chongqing by Jiangsu Zhongbang Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Hongyang Group. Hongyang is a Chinese industrial enterprise supported by advanced manufacturing and manufacturing services, with a full industrial chain integrating scientific research, manufacturing, and marketing. It has assets exceeding 50 billion yuan (including intangible assets), annual sales exceeding 20 billion yuan, and profits of 1 billion yuan. It holds more than a thousand patents and market access approvals. It has 68 wholly-owned and controlling subsidiaries (including one listed company), and has been recognized as one of China's Top 100 in six categories including industry and trademarks, one of China's Top 500 in seven categories including manufacturing and private enterprises, one of the nation's Top Ten Leaders, and one of Asia's Top 500 Brands.
Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a specialized pharmaceutical company integrating scientific research, production, domestic and international trade, and investment, and has obtained a pharmaceutical production GMP certificate. It is mainly engaged in the research and development, production, and sales of pharmaceutical intermediates, active pharmaceutical ingredients, and formulations.
In accordance with government investment promotion requirements, Jiangsu Zhongbang Pharmaceutical Co., Ltd. integrates global resources and, following Hongyang's strategic policy of "independent innovation, differentiated operation, global orientation, and striving for first-class," has invested in and established Chongqing Zhongbang Technology Co., Ltd. in Wanzhou. Chongqing Zhongbang is a national key high-tech company integrating scientific research, manufacturing, and domestic and international markets across the full industrial chain, mainly producing "pyridine series" and "ZPT."